Key result
Angiotensin II receptor blockers demonstrate comparable antihypertensive efficacies within the class, though longer-acting agents may be more effective at providing 24-hour blood pressure control.
Why the study?
Do different Angiotensin II Receptor Blockers have varying efficacy in blood pressure control and heart failure management?
Do different Angiotensin II Receptor Blockers have varying efficacy in blood pressure control and heart failure management?
Answers are grounded in this paper and cite their sources.
While newer ARBs offer longer half-lives for better 24-hour blood pressure control, losartan and valsartan have established evidence for long-term morbidity and mortality benefits in heart failure.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Barreras et al. (2003) conducted a review in Hypertension and heart failure. Angiotensin II Receptor Blockers (ARBs) vs. ACE inhibitors was evaluated. Angiotensin II receptor blockers demonstrate comparable antihypertensive efficacies within the class, though longer-acting agents may be more effective at providing 24-hour blood pressure control.
Synapse has enriched 10 related papers. Consider them for comparative context: